职称:主任医师、教授
联系电话:18672396028
电子邮箱:pengzy5@hotmail.com
个人简介:
长江学者,教授/主任医师,博士生导师,第二届全国创新争先奖章获得者,第十三届中国医师奖获得者,Fellow of American College Critical Care Medicine(USA)。曾任美国匹兹堡大学医学中心危重病医学系助理教授、美国杰克逊纪念医院器官移植麻醉专科医生。现任best365体育最新版本中南医院重症医学科科主任,中华医学会重症医学分会全国常委暨湖北省主任委员、中国研究型医院学会危重医学专业委员会副主任委员、中国医师协会重症医学医师分会常委暨神经重症专家委员会委员、中国医师协会体外生命支持分会常委, 美国重症医学会科学评审委员会委员、欧洲重症学会急性肾损伤专业委员会委员、美国NIH项目评审专家、爱尔兰国家基金评审专家、中国国家自然科学基金评审专家、Joural of Critical Care (USA) 、SHOCK、Blood Purification (Europe)编委等。
研究方向:
脓毒症急性肾损伤的诊断和治疗,生物标志物在脓毒症急性肾损伤的作用和机制,外泌体在脓毒症急性肾损伤的转化研究,重症医学大数据研究
发表论文:
1. Zhang. J., Y. Li and Z. Peng, Prognostic Factors and Efficacy for Continuous Renal Replacement Therapy in Critically Ill Patients: A Chinese Single-Center Retrospective Study. Blood Purif, 2017. 45(1-3): p. 53-60.
2. Peng Z, Yu K, Ostermann M, Xi X, Hsu R, Vincent JL, Prowle JR, Du B, Gallagher M, Wang C, Murugan R, Qiu H, Rimmelé T, Li J, Forni LG, Kashani K, Ronco C, Kellum JA; Acute Disease Quality Initiative (ADQI) Workgroup 19. Pragmatic studies for acute kidney injury: Consensus report of the Acute Disease Quality Initiative (ADQI) 19 Workgroup. J Crit Care. 2018 Apr;44:337-344.
3. Su L, Li Y, Kellum JA, Peng Z*. Predictive value of cell cycle arrest biomarkers for cardiac surgery-associated acute kidney injury: a meta-analysis. Br J Anaesth. 2018 Aug;121(2):350-357.
4. Jiang F, Xiang H, Peng Z*. Incomplete intestinal obstruction as the possible main complaint in Behcet's disease after surgery for recurrent abdominal aortic pseudoaneurysms: a case report and literature review. BMC Cardiovasc Disord. 2018 Dec 17;18(1):238.
5. Sun H, Xie Q, Peng Z*. Does Fenoldopam Protect Kidney in Cardiac Surgery? A Systemic Review and Meta-Analysis With Trial Sequential Analysis. Shock. 2019 Sep;52(3):326-333
6. Jiang F, Su L, Xiang H, Zhang X, Xu D, Zhang Z, Peng Z*. Incidence, Risk factors, and Biomarkers Predicting Ischemic or Hemorrhagic Stroke Associated Acute Kidney Injury and Outcome: A Retrospective Study in a General Intensive Care Unit. Blood Purif. 2019;47(4):317-326.
7. Li Y, Zhang J, Su L, Kellum JA, Peng Z*. Downregulation of TIMP2 attenuates sepsis-induced AKI through the NF-κb pathway. Biochim Biophys Acta Mol Basis Dis. 2019;1865(3):558-569.
8. Su L, Zhang J, Gomez H, Murugan R, Hong X, Xu D, Jiang F, Peng Z*. Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis. Oxid Med Cell Longev. 2019 Oct 13;2019:5080843.
9. Su L,Jiang X, Yang C, Peng Z*. Pannexin 1 mediates ferroptosis that contributes to renal ischemia/reperfusion injury. J Biol Chem. 2019 Dec 13;294(50):19395-19404.
10. Qin Y, Wang G, Peng Z*. MicroRNA-191-5p diminished sepsis-induced acute kidney injury through targeting oxidative stress responsive 1 in rat models. Biosci Rep. 2019 Aug 13;39(8):BSR20190548.
11. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X*, Peng Z*. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069.
12. Shi Q, Zhang X, Jiang F, Zhang X, Hu N, Bimu C, Feng J, Yan S, Guan Y, Xu D, He G, Chen C, Xiong X, Liu L, Li H, Tao J, Peng Z*, Wang W*. Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study. Diabetes Care. 2020 Jul;43(7):1382-1391.
13. Yang X, Cai S, Luo Y, Zhu F, Hu M, Zhao Y, Zheng R, Li X, Hu B*, Peng Z*. Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019-Induced Acute Respiratory Distress Syndrome: A Multicenter Descriptive Study. Crit Care Med. 2020 Sep;48(9):1289-1295.
14. Wang D, Yin Y, Hu C, Liu X, Zhang X, Zhou S, Jian M, Xu H, Prowle J, Hu B, Li Y*, Peng Z*. Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China. Crit Care. 2020 Apr 30;24(1):188.
15. Li Y, Zhai P, Zheng Y, Zhang J, Kellum JA, Peng Z*. Csf2 Attenuated Sepsis-Induced Acute Kidney Injury by Promoting Alternative Macrophage Transition. Front Immunol. 2020 Jul 7;11:1415.
16. Li Y, Long J, Chen J, Zhang J, Qin Y, Zhong Y, Liu F, Peng Z*. Analysis of Spatiotemporal Urine Protein Dynamics to Identify New Biomarkers for Sepsis-Induced Acute Kidney Injury. Front Physiol. 2020 Mar 3;11:139.
17. Hu B, Chen JCY, Dong Y, Frank RD, Passe M, Portner E, Peng Z*, Kashani K*. Effect of initial infusion rates of fluid resuscitation on outcomes in patients with septic shock: a historical cohort study. Crit Care. 2020 Apr 7;24(1):137.
18. Liu F, Zhu Y, Zhang J, Li Y, Peng Z*. Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial. BMJ Open. 2020 Jul 8;10(7):e039519.
19. Xiao X, Tian H, Cheng X, Li G, Zhou J, Peng Z*, Li Y*. Pandoraea sputorum Bacteremia In A Patient Who Had Undergone Allogeneic Liver Transplantation Plus Immunosuppressive Therapy: A Case Report. Infect Drug Resist. 2019 Oct 25;12:3359-3364.
20. Zhou S, Yang Y, Zhang X, Li Z, Liu X, Hu C, Chen C, Wang D*, Peng Z*. Clinical Course of 195 Critically Ill COVID-19 Patients: A Retrospective Multicenter Study. Shock. 2020 Nov;54(5):644-651.
21. Nie Q, Wang D, Ning Z, Li T, Tian X, Bian P, Ding K, Hu C, Peng Z*. Analysis of Severe Fever With Thrombocytopenia Syndrome in Critical Ill Patients in Central China. Shock. 2020 Oct;54(4):451-457.
22. Xuan W, Chen C, Jiang X, Zhang X, Zhu H, Zhang S, Yu W, Peng Z*, Su D*. Clinical characteristics and outcomes of five critical COVID-19 patients treated with extracorporeal membrane oxygenation in Leishenshan Hospital in Wuhan. J Clin Anesth. 2020 Dec;67:110033.
23. Sun H, Jiang H, Eliaz A, Kellum JA, Peng Z*, Eliaz I*. Galectin-3 in septic acute kidney injury: a translational study. Crit Care. 2021 Mar 18;25(1):109.
24. Zhang J, Rao X, Li Y, Zhu Y, Liu F, Guo G, Luo G, Meng Z, De Backer D, Xiang H*, Peng Z*. Pilot trial of high-dose vitamin C in critically ill COVID-19 patients. Ann Intensive Care. 2021 Jan 9;11(1):5.
25. Liu Y, Li Y, Xu D, Zhang J, Peng Z*. Severe COVID-19: Immunosuppression or Hyperinflammation? Shock. 2021 Aug 1;56(2):188-199.
26. Zhu Y, Zhang J, Li Y, Liu F, Zhou Q*, Peng Z*. Association between thrombocytopenia and 180-day prognosis of COVID-19 patients in intensive care units: A two-center observational study. PLoS One. 2021 Mar 18;16(3):e0248671.
27. Jiang J, Zhang J, Liu Y, Xu D, Peng Z*. Urine Output Calculated Using Actual Body Weight May Result in Overestimation of Acute Kidney Injury for Obese Patients. Shock. 2021 Nov 1;56(5):737-743.
28. Liu F, Zhang J, Zhu Y, Su L, Li Y, He L, Yu L, Peng Z*. Acetate Ringer's solution versus 0.9% saline for septic patients: study protocol for a multi-center parallel controlled trial. Trials. 2021 Jan 25;22(1):89.
29. Feng Y, Huang J, Wu J, Xu Y, Chen B, Jiang L, Xiang H, Peng Z*, Wang X*. Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID-19 pneumonia: A pilot study. Cell Prolif. 2020 Dec;53(12):e12947.
30. Feng Y, Peng JY, Peng Z*. Blood purification in sepsis and systemic inflammation. Curr Opin Crit Care. 2021 Dec 1;27(6):582-586.
31. Li L, Qin A, Yang X, Zhou S, Luo Y, Zhu F, Hu B, Li J, Cai S*, Peng Z*. Findings and Prognostic Value of Lung Ultrasonography in Coronal Virus Disease 2019 (COVID-19) Pneumonia. Shock. 2021 Aug 1;56(2):200-205.
32. Peng JY, Li L, Zhao X, Ding F, Hou X, Peng Z*. Hemoperfusion with CytoSorb® in Critically Ill COVID-19 Patients. Blood Purif. 2022;51(5):410-416.
33. Yang X, Li Z, Wang B, Pan Y, Jiang C, Zhang X, Yang Y, Zhou C, Hu C, Zhang Z, Xu H, Liao W, Vizcaychipi MP, Sanders RD, Li Y, Ma D*, Peng Z*. Prognosis and antibody profiles in survivors of critical illness from COVID-19: a prospective multicentre cohort study. Br J Anaesth. 2022 Mar;128(3):491-500.
34. Su L*, Zhang J, Gomez H, Kellum JA, Peng Z*. Mitochondria ROS and mitophagy in acute kidney injury. Autophagy. 2022 Jun 9:1-14.
35. Hu C, Tan Q, Zhang Q, Li Y, Wang F, Zou X*, Peng Z*. Application of interpretable machine learning for early prediction of prognosis in acute kidney injury. Comput Struct Biotechnol J. 2022 Jun 3;20:2861-2870.
36. Li T, Sun H, Li Y, Su L, Jiang J, Liu Y, Jiang N, Huang R, Zhang J, Peng Z*. Downregulation of macrophage migration inhibitory factor attenuates NLRP3 inflammasome mediated pyroptosis in sepsis-induced AKI. Cell Death Discov. 2022 Feb 14;8(1):61.
37. Jiang N, Huang R, Zhang J, Xu D, Li T, Sun Z, Su L*, Peng Z*. TIMP2 mediates endoplasmic reticulum stress contributing to sepsis-induced acute kidney injury. FASEB J. 2022 Apr;36(4):e22228.
38. Cai S, Zhu F, Hu H, Xiang H, Wang D, Wang J, Li L, Yang X, Qin A, Rao X, Luo Y, Li J, Kashani K, Hu B*, Peng Z*, Assessment of respiratory support decision and the outcome of invasive mechanical ventilation in severe COVID-19 with ARDS. Journal of Intensive Medicine 2022, 2(2):92-102.
39. Li T, Zhang J, Long M, Jiang X, Yang C, Wang F, Su L*, Peng Z*. Macrophage Migration Inhibitory Factor Provides a Predictive Performance of Septic Acute Kidney Injury. Shock. 2022 May 1;57(5):666-671.
40. Su L, Zhang J, Peng Z*. The role of kidney injury biomarkers in COVID-19 Ren Fail. 2022;44(1):1280-1288.
41. Hu C, Li Y, Wang F, Peng Z*. Application of Machine Learning for Clinical Subphenotype Identification in Sepsis. Infect Dis Ther. 2022;11(5):1949-1964.
42. Zhu Y, Zhang X, Peng Z*. Consequences of COVID-19 on the cardiovascular and renal systems. Sleep Med. 2022;100:31-38.
43. Ye J, Feng H, Peng Z*. miR-23a-3p inhibits sepsis-induced kidney epithelial cell injury by suppressing Wnt/β-catenin signaling by targeting wnt5a. Braz J Med Biol Res. 2022 Feb 28;55:e11571.
44. Hu C, Li L, Li Y, Wang F, Hu B*, Peng Z*. Explainable Machine-Learning Model for Prediction of In-Hospital Mortality in Septic Patients Requiring Intensive Care Unit Readmission. Infect Dis Ther. 2022 Aug;11(4):1695-1713.
45. Duo H, Li Y, Sun Y, Wei L, Wang Z, Fang F, Zhong Y, Huang J, Luo L*, Peng Z*, Pan H*. Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis. Thromb J. 2022 Aug 23;20(1):47.
46. Zhang R, Tian C, Cai S, Ma J, Li J, Li Z, You J, Ding X*, Peng Z*. Efficacy and Safety of a Low-Flow Extracorporeal Carbon Dioxide Removal System in Acute Respiratory Failure, a Pilot Study in China. Blood Purif. 2022 Jul 27:1-8.
47. Wang F, Zhou L, Eliaz A, Hu C, Qiang X, Ke L, Chertow G, Eliaz I, Peng Z(correspondence). The potential roles of galectin-3 in AKI and CKD. Front Physiol. 2023 Feb 23;14:1090724.
48. Wang F, Li Y, Wang B, Li J, Peng Z. The safety and efficacy of mesenchymal stromal cells in ARDS: a meta-analysis of randomized controlled trials. Crit Care. 2023 Jan 20;27(1):31.
49. Sun Z, Ke L, Zhao Q, Qu J, Hu Y, Gao H, Peng Z(correspondence). The use of bioinformatics methods to identify the effects of SARS-CoV-2 and influenza viruses on the regulation of gene expression in patients. Front Immunol. 2023 Feb 22;14:1098688.
50. Li Y, Zhang J, Zhai P, Hu C, Suo J, Wang J, Liu C, Peng Z(correspondence). The potential biomarker TIFA regulates pyroptosis in sepsis-induced acute kidney injury. Int Immunopharmacol. 2023 Feb;115:109580.
51. Wang, BQ; Wang, Y; Zhang, J; Hu, C; Jiang, J; Li, YM ; Peng, ZY.ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosis. Arch Toxicol.Arch Toxicol. 2023 Jun;97(6):1439-1451.
科研项目:
1. 科技部国家科技重大新药创制重大专项,抗耐药病原菌为主的感染新药临床评价技术平台建设,1466万,2020ZX09201007,2020.01-2020.12
2. 国家自然科学基金(专项项目),Gal-3介导内毒素内化在脓毒症急性肾损伤中的机制及转化研究,82241039,61万元,2023.01-2025.12
3. 国家自然科学基金(面上项目),巨噬细胞外泌体的TIMP-2抑制肾小管上皮细胞泛凋亡在脓毒症急性肾损伤中的作用,82272208,52万,2023.01-2026.12
4. 国家自然科学基金(面上项目),Galectin-3通过TLR4调控肾小管上皮细胞促炎信号的激活在脓毒症急性肾损伤中的作用,81971816,55万,2020-2023
5. 国家自然科学基金(面上项目),TIMP-2调控肾小管上皮细胞分裂周期在脓毒症急性肾损伤中的作用,81772046,56万,2018-2021年
6. 国家自然科学基金(地区项目),生物标志物介导的脓毒症急性肾损伤的血液净化治疗,81560131、37万、2016-2019
7. 湖北省重点研发计划,脓毒症急性肾损伤早期智能化精准诊疗研究,2023BCB015 ,100万,2023.01-2025.12
8. 湖北省科技厅应急攻关专项,静脉注射维生素C在新型冠状病毒相关性重症肺炎治疗的临床应用:一项前瞻随机对照试验,2020FCA024,30万,2020
参编书籍:
1. 急性肾损伤.人民卫生出版社.2024.04,主编
2. 重症医学研究进展(2021),郑州大学出版社,2022年,主编
3. 创伤与急危重症实用技术图解,科学出版社,2021年,主译
4. 重症医学循证实践,山东科学技术出版社,2017.07,副主译
5. CRITICAL CARE NEPHROLOGY(3rd Edition), Saunders Elsevier,编委